2021 Press/Media Releases:

OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment for Symptomatic COVID-19 Outpatients
August 30, 2021

 
     
     
 
   

© 2021 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use